Munafa Stock Market Course + Intraday & FNO calls 
Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)
Technical Analysis Report for USA stock AKTX Akari Therapeutics. Dated: 30 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics
Akari Therapeutics Opened at 0.23 and Closed at: 0.23, which is 0% of previous session's close. It moved within a range of 0.23 and 0.24
The session was a Neutral session with an average volume of 104400, which is -479.21% of previous session's volumes.
A Dead cross was found 7 days back on short term averages
Support for tomorrow is 0.23 and resistance for tomorrow is 0.24
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.23, 0.22 resistance for tomorrow's hourly charts is 0.24, 0.24
10 Day SMA for Akari Therapeutics (AKTX) is 0.26 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Akari Therapeutics (AKTX) is 0.27 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Akari Therapeutics (AKTX) is 0.32 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.57 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Akari Therapeutics is 0.86 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Akari Therapeutics is at 0.27 and 200 DMA is at 0.86, while 50 DMA and 100 DMA are at 0.32 and 0.57 respectively
Akari Therapeutics (AKTX) moving average of 20 SMA is at 0.27 and 20 EMA is at 0.29
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Fri Jan | 0.23 | 0.27 | 0.29 |
| 29 Thu Jan | 0.23 | 0.27 | 0.3 |
| 28 Wed Jan | 0.26 | 0.28 | 0.31 |
| 27 Tue Jan | 0.27 | 0.28 | 0.31 |
| 26 Mon Jan | 0.27 | 0.28 | 0.31 |
| 23 Fri Jan | 0.27 | 0.28 | 0.31 |
Akari Therapeutics (AKTX) moving average of 50 SMA is at 0.32 and 50 EMA is at 0.36
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Fri Jan | 0.23 | 0.32 | 0.36 |
| 29 Thu Jan | 0.23 | 0.33 | 0.37 |
| 28 Wed Jan | 0.26 | 0.33 | 0.38 |
| 27 Tue Jan | 0.27 | 0.34 | 0.38 |
| 26 Mon Jan | 0.27 | 0.34 | 0.38 |
| 23 Fri Jan | 0.27 | 0.35 | 0.38 |
Akari Therapeutics (AKTX) moving average of 100 SMA is at 0.57 and 100 EMA is at 0.49
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Fri Jan | 0.23 | 0.57 | 0.49 |
| 29 Thu Jan | 0.23 | 0.57 | 0.5 |
| 28 Wed Jan | 0.26 | 0.58 | 0.51 |
| 27 Tue Jan | 0.27 | 0.58 | 0.51 |
| 26 Mon Jan | 0.27 | 0.59 | 0.51 |
| 23 Fri Jan | 0.27 | 0.59 | 0.51 |
Akari Therapeutics (AKTX) moving average of 200 SMA is at 0.86 and 200 EMA is at 0.74
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Fri Jan | 0.23 | 0.86 | 0.74 |
| 29 Thu Jan | 0.23 | 0.86 | 0.75 |
| 28 Wed Jan | 0.26 | 0.86 | 0.76 |
| 27 Tue Jan | 0.27 | 0.87 | 0.76 |
| 26 Mon Jan | 0.27 | 0.87 | 0.76 |
| 23 Fri Jan | 0.27 | 0.88 | 0.76 |
Glaukos Corporation has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Glaukos Corporation, about 28.51% more returns!
Cvs Health has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Cvs Health, about 13.79% more returns!
Cardinal Health has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Cardinal Health, about 25.14% more returns!
Twist Bioscience has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 47.49% more returns!
Strata Skin has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Strata Skin, about 16.75% more returns!
Rockwell Medical has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 45.11% more returns!
Neurocrine Biosciences has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 17.46% more returns!
Moderna Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Moderna Inc, about 63.5% more returns!
Medpace Holdings has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Medpace Holdings, about 22.7% more returns!
Lipocine Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Lipocine Inc, about 33.19% more returns!
Lantheus Holdings has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Lantheus Holdings, about 20.17% more returns!
Inovio Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Inovio Pharmaceuticals, about 17.14% more returns!
Fate Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Fate Therapeutics, about 40.89% more returns!
Equillium Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Equillium Inc, about 13.5% more returns!
Cytokinetics Incorporated has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 23.09% more returns!
Arrowhead Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 22.96% more returns!
Aptorum Group has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Aptorum Group, about 9.48% more returns!
Angiodynamics Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Angiodynamics Inc, about 2.39% more returns!
Amarin Corporation has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Amarin Corporation, about 29.44% more returns!
Akari Therapeutics Technical analysis of indicators
Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.
Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Akari Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.26 and Akari Therapeutics AKTX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AKTX Experts View which covers a lot of information including buying and selling signals
AKTX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
